Products by Therapeutic Area PI MG PL SDS
Lexiscan® (regadenoson) injection - -
ASTAGRAF XL® (tacrolimus extended-release capsules) -
Prograf® (tacrolimus) capsules -
Prograf® (tacrolimus) injection -
Prograf® Granules (tacrolimus for oral suspension) -
Infectious Disease
AmBisome® (amphotericin B) liposome for injection - -
CRESEMBA® (isavuconazonium sulfate) capsules -
CRESEMBA® (isavuconazonium sulfate) for injection
Mycamine® (micafungin sodium) for injection - -
PADCEV™ (enfortumab vedotin-ejfv) for injection - - -
Tarceva® (erlotinib) tablets - -
XOSPATA® (gilteritinib) tablets -
XTANDI® (enzalutamide) capsules -
XTANDI® (enzalutamide) tablets - -
Myrbetriq® (mirabegron) extended-release tablets -
VESIcare® (solifenacin succinate) tablets -
VESICARE LS (solifenacin succinate) oral suspension - -
PI=Prescribing Information; MG=Medication Guide; PL=Patient Labeling; SDS=Safety Data Sheet

All trademarks are Astellas except:
  • AmBisome is a registered trademark of Gilead Sciences, Inc.
  • PADCEV is a trademark jointly owned by Agensys, Inc. and Seattle Genetics, Inc.
  • Tarceva is a trademark of OSI Pharmaceuticals, LLC., Farmingdale, NY 11735, USA, an affiliate of Astellas Pharma US, Inc.